Rob Johnson presents at Tianjin Biotech Investor Conference

Rob Johnson will be presenting at the Tianjin International Joint Academy of Biotechnology & Medicine (TJAB) Investor Conference on 8 September 2010.

As the core of China’s BioMed Zone, TJAB has received substantial financial support from the government, with total funding of RMB 1.1 billion.

The Investor Forum is a one-day meeting bringing investors and research teams together to stimulate the growth of a biotechnology industrial sector.


Share on FacebookShare on Google+Tweet about this on TwitterShare on LinkedIn

Stay in touch